Skip to content

Clinical trials

Phase 3 Myocardial Infarction trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 3 Country / region: Czechia Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20062
20071
20081
20091
20101
20111
20135
20141
20161
20191
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated4
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
AstraZeneca2
Pfizer2
Bayer1
Centocor, Inc.1
Cogentus Pharmaceuticals1
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III1
GlaxoSmithKline1
Janssen Research & Development, LLC1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction19
Stroke11
Cardiovascular Diseases9
Acute Coronary Syndrome6
Coronary Artery Disease5
Heart Failure3
Hyperlipidemias3
Angina, Unstable2
Heart Diseases2
Myocardial Ischemia2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.